Explore more publications!

Technology Report Cyprus: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Report Cyprus.

Press releases published on November 24, 2025

Biotech Valuations Rise as New Clinical Platforms Show Progress
Lantheus to Present Florbetaben F 18 Data at CTAD 2025
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform
Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
U.S. Navy Awards SAIC $242M Contract to Operate, Maintain and Upgrade Propulsion Test Facility
Jyong Biotech Ltd. Signs Non‑Binding Letter of Intent with Leading South Korean Pharmaceutical Company to Evaluate In‑Licensing of Plant-Derived MCS Drugs
NordVPN call protection now available for Android users in the UK and Canada
Ramsey Theory Group CEO Dan Herbatschek Identifies the Three Most Significant Cybersecurity Threats for Businesses Coming in December 2025
Texas Border Agency Selects New Non-Lethal Response Subscription to Strengthen Officer and Community Safety
Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025
BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare Conference
Cerevance to Highlight Potential of Solengepras in Parkinson’s Disease at the 2025 Parkinson Study Group Annual Meeting
Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations
IP Strategy Announces Availability of Investor Day 2025 Materials
Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers
Annovis Announces Two Presentations at the CTAD 2025 Conference
ProMIS Neurosciences Announces Reverse Stock Split
Neuphoria Therapeutics Inc. Sends Letter to Stockholders

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions